UiPath (NYSE:PATH) shares closed Friday at $15.05, up 7.5% on the day and 17.9% higher since July 31, marking a notable outperformance against the broader market. The stock's weekly advance outpaced the Nasdaq Composite, which gained 5.2%, and the S&P 500, which rose 3.6% over the same period.
The rally comes amid a favorable macroeconomic backdrop, with Friday's disappointing jobs data driving Treasury yields lower and boosting growth-oriented technology stocks. However, UiPath's surge has pushed its share price 12.3% above the consensus Wall Street target of $13.40, raising questions about sustainability ahead of its upcoming earnings report.
Slowing ARR Growth Raises Concerns
Despite the positive market sentiment, UiPath's fundamentals suggest a challenging quarter ahead. The company's guidance points to approximately $30.5 million in net-new annual recurring revenue (ARR) for the second quarter at the midpoint, a 37.8% decline from the $49 million reported in the first quarter. This calculation is based on analyst estimates rather than official company guidance.
The company's ARR guidance for Q2 stands at $1.929 billion to $1.934 billion, implying a sequential increase that falls short of the previous quarter's growth. Analysts note that a straightforward midpoint figure may now be viewed as insufficient, especially given the company's recent momentum in agentic AI products.
Short Interest and Market Dynamics
Elevated short interest could amplify price swings in either direction. The most recent disclosed short interest stood at 112.93 million shares, representing 28.1% of the float. This figure declined by 18.7% from the prior update, indicating that some bearish bets had already been covered. Friday's trading volume of 62.56 million shares was only slightly above the 65-day average of 60.48 million, making it less likely that the move was solely volume-driven.
The stock's recent rally has been supported by strong first-quarter results, where revenue climbed 17% to $418 million and ARR grew 12% to $1.901 billion. Chief Executive Daniel Dines highlighted that agentic products were "moving from pilot to production," fueling optimism among bulls.
Analyst Sentiment Turned Cautious
Despite the positive price action, analyst sentiment remains cautious. Out of 22 recommendations, 17 are Hold ratings, with only four positive ratings (three Buy and one Overweight). The consensus target price of $13.40 implies an 11% decline from current levels, while the high target of $17.00 offers 13% upside.
Analysts project Q2 revenue of $397.77 million, nearly matching UiPath's guidance midpoint of $397.5 million. The consensus for adjusted earnings has remained steady at $0.15 per share for the past three months. However, non-GAAP operating income is expected to decline to approximately $75 million from $92 million in Q1, reflecting increased investments.
Upcoming Catalysts and Risks
UiPath has scheduled its earnings release for September 3, following the market close. In the meantime, investors will be watching U.S. consumer price data due Wednesday, August 12, producer prices on Thursday, and retail sales on Friday. Stronger-than-expected inflation could push yields higher and weigh on software stocks, while weaker numbers could bolster demand for growth names.
The key risk to the current rally is an ARR miss or a midpoint update that fails to impress. Conversely, an unexpected ARR surge or faster agentic-product conversions could render current analyst forecasts outdated. The upper end of quarterly ARR guidance at $1.934 billion represents the current target; surpassing this mark would provide fundamental backing for the rally, while meeting the midpoint would position the stock above analyst estimates but short of the first-quarter growth rate.
As UiPath heads into its earnings, the market's focus will be on whether the company can deliver on its ARR guidance and justify the recent surge in its share price.
